Integra NeuraGen Nerve Guide Recall: Nonconforming Product Released
Integra LifeSciences recalls NeuraGen nerve guides with part number PNG72 due to nonconforming product mistakenly released for commercial use. Affected units include specific lot numbers.
Lower-risk recall
Nonconforming product which was dispositioned for rejection was mistakenly released for commercial use.
Contact the company
What happened, in plain English
Integra LifeSciences is recalling NeuraGen nerve guides with part number PNG72 because they were mistakenly released for sale after being rejected as nonconforming. This means the product may not meet safety standards and could pose risks. Read more at govinfonow.com/recall/65873-integra-neuragen-nerve-guide-recall-nonconforming-product-released.
Source Summary by GovInfoNow · govinfonow.com/recall/65873-integra-neuragen-nerve-guide-recall-nonconforming-product-released · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1470-2020
Cite this page
“Integra NeuraGen Nerve Guide Recall: Nonconforming Product Released.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/65873-integra-neuragen-nerve-guide-recall-nonconforming-product-released. Based on FDA recall #Z-1470-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1470-2020%22&limit=1).
Why it’s dangerous
The product was rejected as nonconforming but was mistakenly released for sale. This means the item may not meet the required safety standards for medical use, though the specific risk is not detailed in the recall.
Who’s affected
People who own or use the NeuraGen nerve guide with part number PNG72, particularly those who have purchased it for medical nerve repair procedures.
How to tell if you have this one
Check for the part number PNG72 on the product. The nerve guide is 7mm diameter and 2cm length. Lot number 3388360 is associated with this recall.
- Brand
Integra- Category
Medical device
What to do — step by step
Check Product Details
Look for the part number PNG72 and lot number 3388360 on the NeuraGen nerve guide.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 14 states.
FDA distribution: “Worldwide distribution - US Nationwide distribution in the states of AZ, CA, CO, IN, LA, MI, MN, MO, NC, NM, NY, PA, SC, and TX and countries of Italy, France, Germany, and Finland.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Arizona, California, Colorado, Indiana, Louisiana, Michigan, Minnesota, Missouri, New Mexico, New York, North Carolina, Pennsylvania, South Carolina, Texas.
Recall timeline
FDA terminated this recall 4 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1470-2020 (February 7, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1470-2020 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.